286 related articles for article (PubMed ID: 27619752)
1. Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
Jung JJ; Razavian M; Kim HY; Ye Y; Golestani R; Toczek J; Zhang J; Sadeghi MM
Sci Rep; 2016 Sep; 6():32659. PubMed ID: 27619752
[TBL] [Abstract][Full Text] [Related]
2. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
Jung JJ; Razavian M; Challa AA; Nie L; Golestani R; Zhang J; Ye Y; Russell KS; Robinson SP; Heistad DD; Sadeghi MM
J Nucl Med; 2015 Jun; 56(6):933-8. PubMed ID: 25908827
[TBL] [Abstract][Full Text] [Related]
3. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr
Scatena M; Jackson MF; Speer MY; Leaf EM; Wallingford MC; Giachelli CM
Cardiovasc Pathol; 2018; 34():28-37. PubMed ID: 29539583
[TBL] [Abstract][Full Text] [Related]
4. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
[TBL] [Abstract][Full Text] [Related]
5. The role of neutrophil elastase in aortic valve calcification.
Liu Y; Jiang P; An L; Zhu M; Li J; Wang Y; Huang Q; Xiang Y; Li X; Shi Q; Weng Y
J Transl Med; 2022 Apr; 20(1):167. PubMed ID: 35397552
[TBL] [Abstract][Full Text] [Related]
6. Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
Joll JE; Clark CR; Peters CS; Raddatz MA; Bersi MR; Merryman WD
PLoS One; 2020; 15(11):e0238407. PubMed ID: 33237915
[TBL] [Abstract][Full Text] [Related]
7. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
Li C; Xu S; Gotlieb AI
Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
[TBL] [Abstract][Full Text] [Related]
8. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
[TBL] [Abstract][Full Text] [Related]
9. Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification.
Choi B; Kim EY; Kim JE; Oh S; Park SO; Kim SM; Choi H; Song JK; Chang EJ
Cells; 2021 Jan; 10(1):. PubMed ID: 33401457
[TBL] [Abstract][Full Text] [Related]
10. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
Mosch J; Gleissner CA; Body S; Aikawa E
Histol Histopathol; 2017 Mar; 32(3):293-306. PubMed ID: 27353274
[TBL] [Abstract][Full Text] [Related]
11. RAGE deficiency alleviates aortic valve calcification in ApoE
Wang B; Cai Z; Liu B; Liu Z; Zhou X; Dong N; Li F
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):781-792. PubMed ID: 28024939
[TBL] [Abstract][Full Text] [Related]
12. Deletion of calponin 2 attenuates the development of calcific aortic valve disease in ApoE
Plazyo O; Liu R; Moazzem Hossain M; Jin JP
J Mol Cell Cardiol; 2018 Aug; 121():233-241. PubMed ID: 30053524
[TBL] [Abstract][Full Text] [Related]
13. Inflammation is associated with the remodeling of calcific aortic valve disease.
Coté N; Mahmut A; Bosse Y; Couture C; Pagé S; Trahan S; Boulanger MC; Fournier D; Pibarot P; Mathieu P
Inflammation; 2013 Jun; 36(3):573-81. PubMed ID: 23225202
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of calcific aortic valve disease.
Jung JJ; Jadbabaie F; Sadeghi MM
J Nucl Cardiol; 2018 Aug; 25(4):1148-1155. PubMed ID: 29359271
[TBL] [Abstract][Full Text] [Related]
15. Amyloid substance within stenotic aortic valves promotes mineralization.
Audet A; Côté N; Couture C; Bossé Y; Després JP; Pibarot P; Mathieu P
Histopathology; 2012 Oct; 61(4):610-9. PubMed ID: 22642224
[TBL] [Abstract][Full Text] [Related]
16. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis.
Matilla L; Roncal C; Ibarrola J; Arrieta V; García-Peña A; Fernández-Celis A; Navarro A; Álvarez V; Gainza A; Orbe J; Cachofeiro V; Zalba G; Sádaba R; Rodríguez JA; López-Andrés N
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1370-1382. PubMed ID: 32188274
[TBL] [Abstract][Full Text] [Related]
17. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
[TBL] [Abstract][Full Text] [Related]
18. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
20. [Research progress on pharmacotherapy of calcific aortic valve disease].
DU M; Ma G; Shi Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
